or
forgot password

Renal Mass Registry


N/A
18 Years
N/A
Not Enrolling
Both
Renal Cell Carcinoma

Thank you

Trial Information

Renal Mass Registry

Inclusion Criteria


Inclusion:

- Patients with a renal mass or a suspected metastatic lesion from a renal primary who
have been treated or are going to be studied and or treated surgically at Mayo Clinic
Arizona

- Patients must be 18 years of age or older

- Patients must be capable of and willing to sign an informed consent

Exclusion:

None

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label

Outcome Measure:

Evidence of Renal Mass Risk Factors as determined by patient questionnaire post surgery

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Erik Castle, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

13-002688

NCT ID:

NCT01887574

Start Date:

June 2013

Completion Date:

June 2053

Related Keywords:

  • Renal Cell Carcinoma
  • Carcinoma
  • Carcinoma, Renal Cell

Name

Location
Mayo Clinic in Arizona Scottsdale, Arizona  85259-5404